Abstract: Apparatuses, Methods and programs are provided. A method may comprise receiving a first request to verify an identifier associated with a destination from a first requester, responding to the request with a response, the response indicating an existence of a physical address associated with the identifier, the response further comprising a list of authorized entities authorized to access information specifying the physical address, receiving a second request from a second requester to access information specifying the physical address associated with the identifier, determining if the second requester is authorized to have access to information specifying the physical address by analyzing the list of authorized entities corresponding to the identifier; and providing the physical address to the second requester if the second requester is authorized.

Abstract: A package for a micro-electromechanical device (MEMS package) includes an inner enclosure having an inner cavity defined therein, and a fill port channel communicating with the inner cavity and of sufficient length to allow a quantity of adhesive to enter the fill port channel while preventing the adhesive from entering the inner cavity.

Abstract: Embodiments generally disclosed herein include a computer-implemented method for monitoring and correlating network traffic data associated with a primary network that is in communication with a plurality of secondary networks. The method generates a network traffic data set by monitoring network traffic between the primary network and the plurality of secondary networks. The method also determines a mapping of network connectivity by monitoring inter-network routing information between the primary network and the plurality of secondary networks. In addition, the method generates a traffic measurement data set by monitoring network utilization statistics between the primary network and the plurality of secondary networks. With the collected data sets, the method then calculates a relational network mapping between the primary network and the plurality of secondary networks by correlating the network traffic data set, the mapping of network connectivity, and the traffic measurement data set.

Abstract: A compound is represented by Structural Formula (I): or a pharmaceutically acceptable salt thereof. A pharmaceutical composition comprises a compound represented by Structural Formula (I) or a pharmaceutically acceptable salt thereof. A method of treating a subject in need thereof comprises administering to the subject a therapeutically effective amount of a compound represented by Structural Formula (I) or a pharmaceutically acceptable salt thereof. The subject has type 2 diabetes; renal hypertrophy or hyperplasia associated with diabetic nephropathy; Tay-Sachs; Gaucher's; or Fabry's disease. Methods of decreasing plasma TNF-?, lowering blood glucose levels, decreasing glycated hemoglobin levels, inhibiting glucosylceramide synthase, and lowering glycosphingolipid concentrations in a subject in need thereof respectively comprise administering to the subject a therapeutically effective amount of a compound represented by Structural Formula (I) or a pharmaceutically acceptable salt thereof.

Abstract: Embodiments of the invention are related to devices and methods for myocardial ischemia detection, amongst other things. In an embodiment, the invention includes an implantable medical device including control circuitry, an electrical field sensor in communication with the control circuitry, the electrical field sensor configured to generate a signal corresponding to cardiac electrical fields. The implantable medical device can also include a chemical sensor in communication with the control circuitry, the chemical sensor configured to generate a signal corresponding to the concentration of a physiological analyte that affects cardiac electrical field waveform morphology. The control circuitry can be configured to monitor for the presence of myocardial ischemia by evaluating both the signal generated by the electrical field sensor and the signal generated by the chemical sensor. Other embodiments are also included herein.

Abstract: A handheld-sized infrared thermal imaging device (i.e. IR camera) having a focal plane array (FPA) or other type of infrared sensor array, internal memory for storing saved thermal images, a mini-USB or other communications port, battery power supply, and minimal user interface options such as on/off, IR image capture, and potentially a very basic display. The IR camera provides a highly portable field usable thermal image capture instrument which can later be connected to an external computing device such as a laptop computer, with the computer software providing thermal imaging functionality typical of higher end thermal imaging cameras. A visual image camera may be added whereby corresponding visible and IR images are captured and downloadable to the external computer for subsequent thermal analysis.

Abstract: Embodiments generally disclosed herein include a computer-implemented method for monitoring and correlating network traffic data associated with a primary network that is in communication with a plurality of secondary networks. The method generates a network traffic data set by monitoring network traffic between the primary network and the plurality of secondary networks. The method also determines a mapping of network connectivity by monitoring inter-network routing information between the primary network and the plurality of secondary networks. In addition, the method generates a traffic measurement data set by monitoring network utilization statistics between the primary network and the plurality of secondary networks. With the collected data sets, the method then calculates a relational network mapping between the primary network and the plurality of secondary networks by correlating the network traffic data set, the mapping of network connectivity, and the traffic measurement data set.

Abstract: A handheld sized combustion gas sampling analyzer having a gas sample collecting means, an in-line water trap and particulate filter, at least one removable sensor module, with each of the sensor modules adapted to receive at least one sensor chip, and circuitry adapted to receive sensing information from the sensor module and sensor chip thereon.

Abstract: Apparatuses, Methods and programs are provided. A method may comprise receiving a first request to verify an identifier associated with a destination from a first requester, responding to the request with a response, the response indicating an existence of a physical address associated with the identifier, the response further comprising a list of authorized entities authorized to access information specifying the physical address, receiving a second request from a second requester to access information specifying the physical address associated with the identifier, determining if the second requester is authorized to have access to information specifying the physical address by analyzing the list of authorized entities corresponding to the identifier; and providing the physical address to the second requester if the second requester is authorized.

Abstract: In an embodiment, the invention includes an implantable medical device with a pulse generator and a chemical sensor in communication with the pulse generator, the chemical sensor configured to detect an ion concentration in a bodily fluid. In an embodiment, the invention includes a method for providing cardiac arrhythmia therapy to a patient including sensing a physiological concentration of an analyte, communicating data regarding the physiological concentration of the analyte to an implanted pulse generator, and delivering therapy to the patient based in part on the physiological concentration of the ion. In an embodiment, the invention includes a method for monitoring diuretic therapy. In an embodiment, the invention includes a method for controlling delivery of an active agent into a human body. Other aspects and embodiments are provided herein.

Abstract: Implementations described and claimed herein provide systems and methods for balancing network loads across distinct provider networks using enriched network traffic flow data. In one implementation, network traffic flow data representative of network traffic exchanged between a first provider network and a second provider network is generated. The network traffic flow data is enriched using at least one enrichment feed. A network load indication for the first provider network is calculated using the enriched network traffic flow data. The network load indication is a function of a bandwidth measurement and a distance measurement.

Abstract: Implementations described and claimed herein providing systems and methods for modeling and visualizing interconnection relationships between a first provider network and a partner. In one implementation, a partner of a provider network is defined by at least one interconnection point where network traffic may be exchanged between the provider network and the partner. An interconnection relationship is generated based on the at least one interconnection point. The interconnection relationship is modeled.

Abstract: A method of HVAC/R test and measurement using a plurality of test and measurement sensor heads, at least one power source and transmitter unit adapted to physically connect with any of the sensor heads and wirelessly transmit data to an external handheld-sized field use display and analysis instrument, including the steps of connecting the power source and transmitter unit a sensor head; performing a test and measurement by positioning the sensor head to sense and measure the desired parameter; transmitting data to the display and analysis instrument; and receiving the transmitted data on the display and analysis instrument. The display and analysis instrument may be connected to a sensor head, and preferably may receive wired or wirelessly transmitted test and measurement data from any number of communicably connected sensor heads. Wirelessly transmitted data may be received by another external display device such as a smartphone or similar computing device.

Abstract: Embodiments of the invention are related to devices and methods for modulating renal function, amongst other things. In an embodiment, the invention includes a method of modulating renal function in a patient including implanting an occlusive device in the patient, the occlusive device comprising a semi-permeable membrane and configured to expand or contract based on the passage of a fluid across the semi-permeable membrane. Other aspects and embodiments are provided herein.

Abstract: The present invention relates to methods for synthesizing compounds of formula I or pharmaceutically acceptable salts thereof: (I) wherein each of X, Alk, and W are as defined and described herein.

Abstract: A compound is represented by Structural Formula (I): or a pharmaceutically acceptable salt thereof. A pharmaceutical composition comprises a compound represented by Structural Formula (I) or a pharmaceutically acceptable salt thereof. A method of treating a subject in need thereof comprises administering to the subject a therapeutically effective amount of a compound represented by Structural Formula (I) or a pharmaceutically acceptable salt thereof. The subject has type 2 diabetes; renal hypertrophy or hyperplasia associated with diabetic nephropathy; Tay-Sachs; Gaucher's; or Fabry's disease. Methods of decreasing plasma TNF-?, lowering blood glucose levels, decreasing glycated hemoglobin levels, inhibiting glucosylceramide synthase, and lowering glycosphingolipid concentrations in a subject in need thereof respectively comprise administering to the subject a therapeutically effective amount of a compound represented by Structural Formula (I) or a pharmaceutically acceptable salt thereof.

Abstract: A compound for use in treating polycystic kidney disease is represented by Structural Formula (I): or a pharmaceutically acceptable salt thereof. A pharmaceutical composition comprises a compound represented by Structural Formula (I) or a pharmaceutically acceptable salt thereof. A method of treating polycystic kidney disease in a subject in need thereof comprises administering to the subject a therapeutically effective amount of a compound represented by Structural Formula (I) or a pharmaceutically acceptable salt thereof. Methods of treating in polycystic kidney disease in a subject in need thereof respectively comprise administering to the subject a therapeutically effective amount of a compound represented by Structural Formula (I) or a pharmaceutically acceptable salt thereof.

Abstract: A compound for use in treating polycystic kidney disease is represented by Structural Formula (I): or a pharmaceutically acceptable salt thereof. A pharmaceutical composition comprises a compound represented by Structural Formula (I) or a pharmaceutically acceptable salt thereof. A method of treating polycystic kidney disease in a subject in need thereof comprises administering to the subject a therapeutically effective amount of a compound represented by Structural Formula (I) or a pharmaceutically acceptable salt thereof. Methods of treating in polycystic kidney disease in a subject in need thereof respectively comprise administering to the subject a therapeutically effective amount of a compound represented by Structural Formula (I) or a pharmaceutically acceptable salt thereof.